Pharsight

1. Clenpiq patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10624879	FERRING PHARMS INC	Liquid pharmaceutical composition	Jun, 2034 (10 years from now)
US11191753	FERRING PHARMS INC	Liquid pharmaceutical composition	Jun, 2034 (10 years from now)
US9827231	FERRING PHARMS INC	Liquid pharmaceutical composition	Jun, 2034 (10 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
New Patient Population(NPP)	Aug 15, 2021

Market Authorisation Date: 28 November, 2017

Treatment: For cleansing of the colon as a preparation for colonoscopy; For cleansing the large intestine as a preparation for colonoscopy

Dosage: SOLUTION;ORAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
10 mg, 3.5 g, and 12 g	11 Feb, 2019	1		26 Jun, 2034

Strength	Dosage	Availability
12GM/BOT;3.5GM/BOT;10MG/BOT	SOLUTION;ORAL	Prescription

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450338	FERRING PHARMS INC	Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof	Oct, 2028 (4 years from now)
US8481083	FERRING PHARMS INC	Granular compositions of magnesium oxide and citric acid and uses thereof	Oct, 2028 (4 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
New Patient Population(NPP)	Aug 15, 2021
New Product(NP)	Jul 16, 2015

Market Authorisation Date: 16 July, 2012

Treatment: NA

Dosage: FOR SOLUTION;ORAL